Member Info for cmww2014

Polygon have bought 300,000 shares according to the RNS. this doesn't seem enough to 'prop up the share price'.
Do you think they continued buying after reaching 8% or is there other 'aggressive buyers' that have now stopped?

Sound like a prediction from the self styled Prediction ombudsmen SBM.

And same here, had to break up into ~200 share buys (@187p)

I just went out for a run to deliberate this.

Is it possible we will get further details on the trial cohort; e.g. numbers from each country, age breakdown, Asthmatics etc ?

Don't see why this information would need to remain under wraps now all patients have been dosed

Almost certainly, Teflon de pfaffel

Richard is at the wheel

Agree superritch! though the trail they blaze should allow SNG to sell a treatment for c.2k

Weird angle being taken suggesting that we've spent enough on covid

Talking about Mercks smarties

Ah the sequencing lag is 5-7 days
https://www.google.com/amp/s/news.sky.com/story/amp/covid-19-how-is-the-uk-testing-for-the-omicron-variant-12482173

I'm not sure we're doing that many either BG ... would love to hear what percentage of positive tests are sequenced.

The lack of S gene detection is why it is also easy to identify with a PCR
Tomorrow will be a bad day for omicron in the UK

8 is an absolute joke, the true number is in the hundreds.
The PCR test indicates exposes differently with an Omicron sample but of course they still need to be sequenced which (I'm assuming) is the hold up to the true figure.

Oh absolutely Wyndrum.
Though I'd prefer to read positivity from posters I've read for a while rather than some holier than though sh**e from a poster just arrived.

Watching; what's this you wrote on another board ?
>>
Helps me lower my average lol
Thanks
I’ve Asked around news soooo close

Novatis have a lot of cash and a lack of product after selling off Roche and Sandoz

Girlfriend works in a testing lab. They're seeing plenty of suspected Omicron positives as the PCR exposes differently.

Down another $9bilion

4.23% down in pre-market ! - just the $9billion then !

50% efficacy on first 700 (ish)
30% efficacy after 1400 (ish)

so the second 700 (ish) showed just a 10% 'reduction in hospitalizations and deaths'

Ouch !